223 related articles for article (PubMed ID: 25738504)
1. Circulating microRNA-196a as a candidate diagnostic biomarker for chronic hepatitis C.
Liu B; Xiang Y; Zhang HS
Mol Med Rep; 2015 Jul; 12(1):105-10. PubMed ID: 25738504
[TBL] [Abstract][Full Text] [Related]
2. Dysregulated Serum MicroRNA Expression Profile and Potential Biomarkers in Hepatitis C Virus-infected Patients.
Zhang S; Ouyang X; Jiang X; Gu D; Lin Y; Kong SK; Xie W
Int J Med Sci; 2015; 12(7):590-8. PubMed ID: 26283876
[TBL] [Abstract][Full Text] [Related]
3. Circulating microRNAs as predictive biomarkers for liver disease progression of chronic hepatitis C (genotype-4) Egyptian patients.
El-Hefny M; Fouad S; Hussein T; Abdel-Hameed R; Effat H; Mohamed H; Abdel Wahab AH
J Med Virol; 2019 Jan; 91(1):93-101. PubMed ID: 30133717
[TBL] [Abstract][Full Text] [Related]
4. Serum microRNA panels as potential biomarkers for early detection of hepatocellular carcinoma on top of HCV infection.
Zekri AN; Youssef AS; El-Desouky ED; Ahmed OS; Lotfy MM; Nassar AA; Bahnassey AA
Tumour Biol; 2016 Sep; 37(9):12273-12286. PubMed ID: 27271989
[TBL] [Abstract][Full Text] [Related]
5. Parallel expression profiling of hepatic and serum microRNA-122 associated with clinical features and treatment responses in chronic hepatitis C patients.
Butt AM; Raja AJ; Siddique S; Khan JS; Shahid M; Tayyab GU; Minhas Z; Umar M; Idrees M; Tong Y
Sci Rep; 2016 Feb; 6():21510. PubMed ID: 26898400
[TBL] [Abstract][Full Text] [Related]
6. Elevated serum microRNA-122/222 levels are potential diagnostic biomarkers in Egyptian patients with chronic hepatitis C but not hepatic cancer.
Motawi TM; Sadik NA; Shaker OG; Ghaleb MH
Tumour Biol; 2016 Jul; 37(7):9865-74. PubMed ID: 26812693
[TBL] [Abstract][Full Text] [Related]
7. Expression profiling of miRNA-196a biomarker in naïve hepatitis C virus-infected and Sofosbuvir plus Daclatasvir-treated patients.
Hussain N; Farooq N; Maqsood M; Rajoka MSR; Bilal M
Arch Microbiol; 2021 Jul; 203(5):2365-2371. PubMed ID: 33660021
[TBL] [Abstract][Full Text] [Related]
8. Circulating miRNA-122, miRNA-199a, and miRNA-16 as Biomarkers for Early Detection of Hepatocellular Carcinoma in Egyptian Patients with Chronic Hepatitis C Virus Infection.
El-Abd NE; Fawzy NA; El-Sheikh SM; Soliman ME
Mol Diagn Ther; 2015 Aug; 19(4):213-20. PubMed ID: 26133725
[TBL] [Abstract][Full Text] [Related]
9. Serum interferon-related microRNAs as biomarkers to predict the response to interferon therapy in chronic hepatitis C genotype 4.
Motawi TK; Shaker OG; El-Maraghy SA; Senousy MA
PLoS One; 2015; 10(3):e0120794. PubMed ID: 25790297
[TBL] [Abstract][Full Text] [Related]
10. MicroRNA-122 associates with serum apolipoprotein B but not liver fibrosis markers in CHC genotype 1 infection.
Lee TH; Matta B; King BD; Hodges MR; Tillmann HL; Patel K
J Med Virol; 2015 Oct; 87(10):1722-6. PubMed ID: 25963774
[TBL] [Abstract][Full Text] [Related]
11. [Evaluation of miR-122 level in the plasma of chronically HCV infected patients].
Gholami M; Ravanshad M; Alavian SM; Baesi K; Moallemi S
Mol Biol (Mosk); 2016; 50(2):279-83. PubMed ID: 27239848
[TBL] [Abstract][Full Text] [Related]
12. Serum microRNA expression profiling identifies serum biomarkers for HCV-related hepatocellular carcinoma.
Li J; Jin B; Wang T; Li W; Wang Z; Zhang H; Song Y; Li N
Cancer Biomark; 2019; 26(4):501-512. PubMed ID: 31658041
[TBL] [Abstract][Full Text] [Related]
13. Expression analysis of liver-specific circulating microRNAs in HCV-induced hepatocellular Carcinoma in Egyptian patients.
Mourad L; El-Ahwany E; Zoheiry M; Abu-Taleb H; Hassan M; Ouf A; Rahim AA; Hassanien M; Zada S
Cancer Biol Ther; 2018 May; 19(5):400-406. PubMed ID: 29333940
[TBL] [Abstract][Full Text] [Related]
14. Serum miR-122 as a biomarker of necroinflammation in patients with chronic hepatitis C virus infection.
Bihrer V; Friedrich-Rust M; Kronenberger B; Forestier N; Haupenthal J; Shi Y; Peveling-Oberhag J; Radeke HH; Sarrazin C; Herrmann E; Zeuzem S; Waidmann O; Piiper A
Am J Gastroenterol; 2011 Sep; 106(9):1663-9. PubMed ID: 21606975
[TBL] [Abstract][Full Text] [Related]
15. Circulating microRNA-196a/b are novel biomarkers associated with metastatic gastric cancer.
Tsai MM; Wang CS; Tsai CY; Huang CG; Lee KF; Huang HW; Lin YH; Chi HC; Kuo LM; Lu PH; Lin KH
Eur J Cancer; 2016 Sep; 64():137-48. PubMed ID: 27420607
[TBL] [Abstract][Full Text] [Related]
16. Diagnostic value of circulating miRNA-122 for hepatitis B virus and/or hepatitis C virus-associated chronic viral hepatitis.
Zhou X; Fang S; Wang M; Xiong A; Zheng C; Wang J; Yin C
Biosci Rep; 2019 Sep; 39(9):. PubMed ID: 31427483
[No Abstract] [Full Text] [Related]
17. Serum microRNA-21 as marker for necroinflammation in hepatitis C patients with and without hepatocellular carcinoma.
Bihrer V; Waidmann O; Friedrich-Rust M; Forestier N; Susser S; Haupenthal J; Welker M; Shi Y; Peveling-Oberhag J; Polta A; von Wagner M; Radeke HH; Sarrazin C; Trojan J; Zeuzem S; Kronenberger B; Piiper A
PLoS One; 2011; 6(10):e26971. PubMed ID: 22066022
[TBL] [Abstract][Full Text] [Related]
18. miRNA-221 and miRNA-222 are promising biomarkers for progression of liver fibrosis in HCV Egyptian patients.
Abdel-Al A; El-Ahwany E; Zoheiry M; Hassan M; Ouf A; Abu-Taleb H; Abdel Rahim A; El-Talkawy MD; Zada S
Virus Res; 2018 Jul; 253():135-139. PubMed ID: 29932949
[TBL] [Abstract][Full Text] [Related]
19. Serum MiRNA panel as potential biomarkers for chronic hepatitis B with persistently normal alanine aminotransferase.
Tan Y; Ge G; Pan T; Wen D; Gan J
Clin Chim Acta; 2015 Dec; 451(Pt B):232-9. PubMed ID: 26483130
[TBL] [Abstract][Full Text] [Related]
20. Differences in serum microRNA profiles in hepatitis B and C virus infection.
Akamatsu S; Hayes CN; Tsuge M; Miki D; Akiyama R; Abe H; Ochi H; Hiraga N; Imamura M; Takahashi S; Aikata H; Kawaoka T; Kawakami Y; Ohishi W; Chayama K
J Infect; 2015 Mar; 70(3):273-87. PubMed ID: 25452043
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]